The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 22, 2011
Filed:
Apr. 26, 2006
Raymond A. Dwek, Oxford, GB;
Umi Marshida Abd Hamid, Oxford, GB;
Rafael DE Llorens, 1-3, 17820 Banyoles, ES;
Rosa Peracaula, 3-3, 17003 Girona, ES;
Catherine M. Radcliffe, Caversham, Reading, GB;
John Robertson, Attenborough, Beeston, GB;
Louise Royle, Oxon, GB;
Pauline M. Rudd, Abingdon, GB;
Nicole Zitzmann, Oxford, GB;
Raymond A. Dwek, Oxford, GB;
Umi Marshida Abd Hamid, Oxford, GB;
Rafael de Llorens, 1-3, 17820 Banyoles, ES;
Rosa Peracaula, 3-3, 17003 Girona, ES;
Catherine M. Radcliffe, Caversham, Reading, GB;
John Robertson, Attenborough, Beeston, GB;
Louise Royle, Oxon, GB;
Pauline M. Rudd, Abingdon, GB;
Nicole Zitzmann, Oxford, GB;
Other;
Abstract
One can identify and quantify one or more glycosylation markers of cancer by utilizing quantitative HPLC analysis of glycans which have been released from unpurified glycoproteins. The unpurified glycoproteins can be total glycoproteins or a selection of the total glycoproteins. The identified glycosylation marker can be a native glycan or a digestion product which has been segregated and amplified by exoglycosidase digestions. One can utilize the identified glycosylation marker, for example, for diagnosing and/or monitoring cancer in a subject. One can also use the glycosylation marker to identify glycoprotein biomarkers that carry the glycosylation marker. Such biomarkers can also be used for monitoring and/or diagnosing cancer. The biomarker may also be a subset of glycoforms of a glycoprotein that are separated in trains of spots on 2D gel.